PubMed Journals Articles About "Bolus Vs IVP (Intravenous Push) Diltiazem For Atrial Fibrillation Or Flutter" RSS

00:33 EST 27th January 2020 | BioPortfolio

Bolus Vs IVP (Intravenous Push) Diltiazem For Atrial Fibrillation Or Flutter PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Bolus Vs IVP (Intravenous Push) Diltiazem For Atrial Fibrillation Or Flutter articles that have been published worldwide.

More Information about "Bolus Vs IVP (Intravenous Push) Diltiazem For Atrial Fibrillation Or Flutter" on BioPortfolio

We have published hundreds of Bolus Vs IVP (Intravenous Push) Diltiazem For Atrial Fibrillation Or Flutter news stories on BioPortfolio along with dozens of Bolus Vs IVP (Intravenous Push) Diltiazem For Atrial Fibrillation Or Flutter Clinical Trials and PubMed Articles about Bolus Vs IVP (Intravenous Push) Diltiazem For Atrial Fibrillation Or Flutter for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bolus Vs IVP (Intravenous Push) Diltiazem For Atrial Fibrillation Or Flutter Companies in our database. You can also find out about relevant Bolus Vs IVP (Intravenous Push) Diltiazem For Atrial Fibrillation Or Flutter Drugs and Medications on this site too.

Showing "Bolus Intravenous Push Diltiazem Atrial Fibrillation Flutter" PubMed Articles 1–25 of 2,200+

Impact of atrial fibrillation/flutter on the in-hospital mortality of ischemic stroke patients.

Stroke is the second leading cause of death worldwide. Ischemic strokes, which are caused by atrial fibrillation/flutter (AF) may be more devastating than those without AF.

Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke?

The association between atrial fibrillation and stroke is firmly established, and anticoagulation reduces stroke risk in patients with atrial fibrillation. However, the role of anticoagulation in very brief durations of atrial fibrillation (subclinical atrial fibrillation) is an area of controversy.

Postoperative Atrial Fibrillation and Flutter in Liver Transplantation: An Important Predictor of Early and Late Morbidity and Mortality.

Postoperative atrial fibrillation/flutter (POAF) is the most common perioperative arrhythmia and may be particularly problematic after liver transplant (LT). This study is a single-center, retrospective analysis of POAF to determine its incidence following LT, identify risk factors, assess its impact on clinical outcomes, and summarize management strategies.

Prognostic impact of atrial fibrillation and flutter temporal pattern on anticoagulation and return visits to the emergency department: A historic cohort of 1112 patients.

Emergency department (ED) visits due to atrial fibrillation and flutter (AFF) are common, and provide an opportunity to define stroke risk. The prognostic impact of AFF duration on return ED visits is unknown. We aimed to investigate both the prognostic impact of AFF classification on ED visits and the adherence to guideline recommendations on anticoagulation.

Atopic dermatitis and risk of atrial fibrillation or flutter: a 35-year follow-up study.

Atopic dermatitis is characterized by chronic inflammation, which is a risk factor for atrial fibrillation.

Early recurrence of atrial tachyarrhythmia during the 90-day blanking period after cryoballoon ablation in patients with atrial fibrillation: The characteristics and predictive value of early recurrence on long-term outcomes.

To investigate the characteristics of early recurrence (ER) of atrial tachyarrhythmia (ATA) defined as atrial fibrillation (AF), atrial tachycardia (AT), or atrial flutter (AFL) during a 90-day blanking period after pulmonary vein isolation by cryoablation (PVI-C) in patients with symptomatic drug refractory AF. Specifically, to determine if ER of ATA during the blanking period can predict late recurrence (LR) during a 12-month follow-up period.

Atrial Fibrillation and Preexcitation - A Licence to Kill.

Atrial fibrillation becomes a potentially lethal arrhythmia in the presence of preexcitation because the rapid ventricular activation can result in ventricular fibrillation. Fortunately, radiofrequency ablation is an effective treatment for these patients. Specific points of interest regarding this association are the mechanism of increased incidence of atrial fibrillation and the current management of patients presenting in atrial fibrillation. These are discussed in this editorial.

Alcohol Abstinence in Drinkers with Atrial Fibrillation.

Excessive alcohol consumption is associated with incident atrial fibrillation and adverse atrial remodeling; however, the effect of abstinence from alcohol on secondary prevention of atrial fibrillation is unclear.

Alcohol Abstinence in Drinkers with Atrial Fibrillation.

Excessive alcohol consumption is associated with incident atrial fibrillation and adverse atrial remodeling; however, the effect of abstinence from alcohol on secondary prevention of atrial fibrillation is unclear.

Does mitral regurgitation reduce the risk of thrombosis in atrial fibrillation and flutter?

Blood stasis is the main cause of left atrial thrombosis (LAT) in atrial tachyarrhythmias. The high-velocity flow inside the left atrium, due to mitral valve regurgitation, may prevent clot formation but the topic has never been investigated in large-scale studies. The aim of our study was to evaluate whether the presence and degree of mitral regurgitation have a protective role against LAT risk.

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation often recurs after restoration of normal sinus rhythm. Antiarrhythmic drugs have been widely used to prevent recurrence. This is an update of a review previously published in 2006, 2012 and 2015.

Protocol for a systematic review and network meta-analysis of the management of new onset atrial fibrillation in critically unwell adult patients.

New onset atrial fibrillation is the most commonly encountered arrhythmia in critically unwell patients with a reported incidence of 4% to 29%. The occurrence of new onset atrial fibrillation may precipitate acute heart failure and lead to thromboembolic complications as well as being associated with increased in-hospital and in intensive care unit (ICU) mortality. Despite being common, much of our current knowledge regarding the treatment of new onset atrial fibrillation comes from patients with chronic at...

Perioperative Atrial Fibrillation in Noncardiac Surgeries for Malignancies and One-Year Recurrence.

Perioperative atrial fibrillation (POAF) in noncardiac surgeries is common. However, it is unclear whether such atrial fibrillation (AF) recurs in the long term.

A Computational Fluid Dynamics Approach for Personalized Stroke Risk Assessment in Atrial Fibrillation.

Atrial fibrillation increases the risk of cerebrovascular events, being responsible of 15-18% of all strokes. The morphological and functional remodelling of the left atrium caused by atrial fibrillation favours blood stasis and, consequently, stroke risk. Several studies suggest that haemodynamic information on the left atrium and the left atrial appendage may help to better characterize stroke risk. The aim of this study was to develop a personalized computational fluid dynamics model of the left atrium w...

Outcomes in newly diagnosed atrial fibrillation and history of acute coronary syndromes: insights from GARFIELD-AF.

Many patients with atrial fibrillation have concomitant coronary artery disease with or without acute coronary syndromes and are in the need of additional antithrombotic therapy. There are few data on the long-term clinical outcome of atrial fibrillation patients with a history of acute coronary syndrome. This is a 2-year study of atrial fibrillation patients with or without a history of acute coronary syndromes.

Tissue Doppler-derived atrial dyssynchrony predicts new-onset atrial fibrillation during hospitalization for ST-elevation myocardial infarction.

Atrial dyssynchrony, but not atrial enlargement/dysfunction, reflects acute atrial histopathological changes. It has been shown to be associated with new-onset atrial fibrillation (NOAF) in various clinical conditions but was not studied in the acute phase of ST-elevation myocardial infarction (STEMI) which is the aim of the current study.

Mechanical atrial recovery after cardioversion in persistent atrial fibrillation evaluated by bidimensional speckle tracking echocardiography.

Atrial fibrillation induces reversible electrical and mechanical modifications (atrial remodeling). Atrial stunning is a mechanical dysfunction with preserved bioelectrical function, occurring after successful atrial fibrillation electrical cardioversion (ECV). Two-dimensional speckle tracking echocardiography is a new technology for evaluating atrial mechanical function. We assessed atrial mechanical function after ECV with serial two-dimensional speckle tracking echocardiography evaluations. The investiga...

Safety of uninterrupted direct oral anticoagulants for ambulatory common atrial flutter catheter ablation: a propensity score-matched cohort study.

Same-day home discharge after common atrial flutter catheter ablation (CAFCA) is a feasible, safe and cost-effective practice, but there is currently no data concerning patients treated with direct oral anticoagulants (DOAs).

Atrial Flutter and Fibrillation Following Lung Transplantation: Incidence, Associations and a Suggested Therapeutic Algorithm.

Atrial arrhythmias are relatively common following lung transplantation and confer considerable perioperative risk, specifically haemodynamic instability, pulmonary congestion, dyspnoea, and can mask other post-transplant complications such as infection or acute rejection. However, for most patients, arrhythmias are limited to the short-term perioperative period.

The association between atrial fibrillation and Alzheimer's disease: fact or fallacy? A systematic review and meta-analysis.

The association between atrial fibrillation and dementia has been described. Whether a specific association exists between atrial fibrillation and Alzheimer's disease remains uncertain. This study aims to assess the association between atrial fibrillation and Alzheimer's disease through a systematic review and meta-analysis of the literature.

Effect of acute and chronic ethanol on atrial fibrillation vulnerability in rats.

Even though ethanol consumption has been associated with risk of atrial fibrillation (AF), little is known about how ethanol affects atrial electrophysiology.

Anatomic Considerations Relevant to Atrial and Ventricular Arrhythmias.

Knowledge of relevant cardiac anatomy is crucial in understanding the pathophysiology and treatment of arrhythmias, and helps avoid potential complications in mapping and ablation. This article explores the anatomy, relevant to electrophysiologists, relating to atrial flutter and atrial fibrillation, ventricular tachycardia relating to the outflow tracts as well as endocardial structure, and also epicardial considerations for mapping and ablation.


Ibrutinib, the first in class of BTK inhibitor, has improved the management of patients with chronic lymphocytic leukemia. Since ibrutinib can cause atrial fibrillation in 6-16% of cases, it is clinically relevant to identify patients at higher risk to develop atrial fibrillation. Comorbidities associated with a higher risk to develop atrial fibrillation were recapitulated in a scoring system. This model proved to be a valid prognostic tool both in a general chronic lymphocytic leukemia population (n=860) a...

Left atrial size and total atrial emptying fraction in atrial fibrillation progression.

Left atrial (LA) size and low voltage areas (LVA) mirror atrial fibrillation (AF) progression. Whether these factors are important for the impairment of total atrial emptying fraction is understudied.

Atrial flutter with underlying left atrial myxoma.

Quick Search